Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Just sent them all the following:
Hello, I've been with MRKR since early TPIV, am down about 150K.

Taking into consideration the following:
November 10, 2021: Q3 2021 Update PR
“Topline readout of Group 2 active disease anticipated in Q1 2022"

March 17, 2022: YE 2021 Update PR
“Topline readout of Group 2 active disease anticipated in Q2 2022”

May 13, 2022: Q1 2022 Update PR
“Topline readout of Group 2 active disease is anticipated in Q2 2022”

August 11, 2022: Q2 2022 Update PR
“We expect to provide a topline readout of active disease patients in Q3 2022”

And since not a single time was any explanation given as to why the data date was missed, do you have any kind of accurate estimate of when Topline readout of Group 2 active disease will actually be released?

Thank You